{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:52:32Z","timestamp":1772160752135,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003466","name":"University of Leeds Faculty of Medicine and Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003466","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.anaerobe.2021.102385","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T12:27:54Z","timestamp":1621945674000},"page":"102385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities"],"prefix":"10.1016","volume":"70","author":[{"given":"Vernon","family":"Jon J","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilcox","family":"Mark H","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9580-4586","authenticated-orcid":false,"given":"Freeman","family":"Jane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2021.102385_bib1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmi.2017.10.008","article-title":"The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011\u20132014","volume":"24","author":"Freeman","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.anaerobe.2021.102385_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/2049936115622891","article-title":"Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection","volume":"3","author":"Spigaglia","year":"2016","journal-title":"Therapeutic advances in infectious disease"},{"key":"10.1016\/j.anaerobe.2021.102385_bib3","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/jac\/dkr292","article-title":"Multidrug resistance in European Clostridium difficile clinical isolates","volume":"66","author":"Spigaglia","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2021.102385_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ng.2478","article-title":"Emergence and global spread of epidemic healthcare-associated Clostridium difficile","volume":"45","author":"He","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.anaerobe.2021.102385_bib5","doi-asserted-by":"crossref","first-page":"248 e9","DOI":"10.1016\/j.cmi.2014.09.017","article-title":"Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes","volume":"21","author":"Freeman","year":"2015","journal-title":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"key":"10.1016\/j.anaerobe.2021.102385_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1099\/jmm.0.014829-0","article-title":"Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979\u20132004","volume":"59","author":"Taori","year":"2010","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2021.102385_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10096-019-03708-7","article-title":"Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study","volume":"39","author":"Freeman","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2021.102385_bib8","series-title":"Clostridium difficile Ribotyping Network (CDRN) for England and Northern Ireland - Biennial Report (2013-2015)","year":"2016"},{"key":"10.1016\/j.anaerobe.2021.102385_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/JCM.37.2.461-463.1999","article-title":"PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes","volume":"37","author":"Stubbs","year":"1999","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2021.102385_bib10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/cid\/cis614","article-title":"Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England","volume":"55","author":"Wilcox","year":"2012","journal-title":"Clin. Infect. Dis. : an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.anaerobe.2021.102385_bib11","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1128\/iai.56.9.2299-2306.1988","article-title":"Actin-specific ADP-ribosyltransferase produced by A clostridium-difficile strain","volume":"56","author":"Popoff","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.anaerobe.2021.102385_bib12","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa051590","article-title":"An epidemic, toxin gene-variant strain of Clostridium difficile","volume":"353","author":"McDonald","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.anaerobe.2021.102385_bib13","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1128\/AAC.46.11.3418-3421.2002","article-title":"gyrA and gyrB mutations are implicated in cross-resistance to ciprofloxacin and moxifloxacin in Clostridium difficile","volume":"46","author":"Dridi","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2021.102385_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/jac\/dky535","article-title":"Effect of fluoroquinolone resistance mutation Thr-82\u2192 Ile on Clostridioides difficile fitness","volume":"74","author":"Vernon","year":"2018","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2021.102385_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2180-14-173","article-title":"International Clostridium difficile animal strain collection and large diversity of animal associated strains","volume":"14","author":"Janezic","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.anaerobe.2021.102385_bib16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1128\/JCM.03297-14","article-title":"Evaluation of the cepheid xpert C.\u00a0difficile epi and meridian bioscience illumi gene C.\u00a0difficile assays for detecting Clostridium difficile ribotype 033 strains","volume":"53","author":"Androga","year":"2015","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2021.102385_bib17","first-page":"235","article-title":"Clostridium difficile ribotype 033 colitis in a patient following broad-spectrum antibiotic treatment for KPC-producing Klebsiella pneumoniae infection","volume":"39","author":"Grandesso","year":"2016","journal-title":"Italy. New Microbiol"},{"key":"10.1016\/j.anaerobe.2021.102385_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nmni.2014.10.003","article-title":"Prevalence and pathogenicity of binary toxin\u2013positive Clostridium difficile strains that do not produce toxins A and B","volume":"3","author":"Eckert","year":"2015","journal-title":"New Microbes and New Infections"},{"key":"10.1016\/j.anaerobe.2021.102385_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00446-19","article-title":"Evolutionary and genomic insights into Clostridioides difficile sequence type 11: a diverse zoonotic and antimicrobial-resistant lineage of global one Health importance","volume":"10","author":"Knight","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.anaerobe.2021.102385_bib20","series-title":"A\u00a0Role for Tetracycline Selection in the Evolution of Clostridium difficile PCR-Ribotype 078","author":"Dingle","year":"2018"},{"key":"10.1016\/j.anaerobe.2021.102385_bib21","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1038\/s41598-017-10155-x","article-title":"CD2068 potentially mediates multidrug efflux in Clostridium difficile","volume":"7","author":"Ngernsombat","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.anaerobe.2021.102385_bib22","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/AAC.01292-15","article-title":"Protective effect of qnr on agents other than quinolones that target DNA gyrase","volume":"59","author":"Jacoby","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2021.102385_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02584","article-title":"Antibiotic resistance and toxin production of Clostridium difficile isolates from the hospitalized patients in a large hospital in Florida","volume":"8","author":"Peng","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.anaerobe.2021.102385_bib24","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s10096-010-1017-9","article-title":"Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008","volume":"29","author":"Ilchmann","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2021.102385_bib25","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1128\/AAC.49.6.2550-2553.2005","article-title":"ErmB determinants and Tn916-Like elements in clinical isolates of Clostridium difficile","volume":"49","author":"Spigaglia","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2021.102385_bib26","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1086\/428835","article-title":"Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998","volume":"40","author":"Tang-Feldman","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2021.102385_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jac\/dkg112","article-title":"Prevalence and association of macrolide-lincosamide- streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile","volume":"51","author":"Ackermann","year":"2003","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2021.102385_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1099\/jmm.0.45790-0","article-title":"Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630\u0394erm) and demonstration that the conjugative transposon Tn916\u0394E enters the genome of this strain at multiple sites","volume":"54","author":"Hussain","year":"2005","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2021.102385_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.02000-15","article-title":"Susceptibility of Clostridium difficile isolates of varying antimicrobial resistance phenotypes to SMT19969 and 11 comparators","volume":"60","author":"Freeman","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2021.102385_bib30","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1128\/AAC.00419-13","article-title":"The comprehensive antibiotic resistance database","volume":"57","author":"McArthur","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2021.102385_bib31","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/jac\/dks261","article-title":"Identification of acquired antimicrobial resistance genes","volume":"67","author":"Zankari","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996421000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996421000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:39:11Z","timestamp":1761035951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996421000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":31,"alternative-id":["S1075996421000688"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2021.102385","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2021.102385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102385"}}